Expression of Bax, Bad and Bcl-2 proteins under X-radiation effect towards human breast carcinoma MCF-7 cells and their doxorubicin-resistant derivatives

Experimental Oncology

Volumn 27, Issue 3, 2005, Pages 196-201

  Chorna, I V ^a,b   Datsyuk, L O ^b   Stoika, R S ^a,b  

^a INSTITUTE OF CELL BIOLOGY   (Ukraine)

^b IVAN FRANKO NATIONAL UNIVERSITY OF LVIV   (Ukraine)

Author keywords

Bad; Bax; Bcl 2; DNA damage; DNA repair; Doxorubicin resistance; MCF 7 human breast carcinoma cells; X radiation

Indexed keywords

CISPLATIN; DOXORUBICIN; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CELL STRAIN; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IRRADIATION; PROTEIN EXPRESSION; RADIOSENSITIVITY; STRAIN DIFFERENCE; X RAY;

ANTIBIOTICS, ANTINEOPLASTIC; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; BREAST NEOPLASMS; CARCINOMA; COMET ASSAY; DNA DAMAGE; DNA REPAIR; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 27744586348     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 1995; 13: 2869-78.
2. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 2003; 278: 31401-11.
3. Boulikas T, Vougiouka M. Cisplatin and platinum drugs at the molecular level. Oncol Rep 2003; 10: 1663-82.
4. Burlacu A. Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 2003; 7: 249-57.
5. Chorna I, Bilyy R, Datsyuk L, Stoika R. Comparative study of human breast carcinoma MCF-7 cells differing in their resistance to doxorubicin: effect of ionizing radiation on apoptosis and TGF-β production. Exp Oncol 2004; 26: 111-7.
6. Cohen SM, Lippard SJ. Cisplatin: from DNA damage to cancer chemotherapy. Prog Nucleic Acid Res Mol Biol 2001; 67: 93-130.
7. Collins AR, Dusinska M, Franclin M, Somorovska M, Petrovska H, Duthie S, Fillion L, Panayiotidis M, Raslova K, Vaughan N. Comet assay in human biomonitoring studies: reliability, validation and applications. Environ Mol Mutagen 1997; 30: 139-46.
8. Condorelli F, Salomoni P, Cotteret S, Cesi V, Srinivasula SM, Alnemri ES, Calabretta B. Caspase cleavage enhances the apoptosis-inducing effects of BAD. Mol Cell Biol 2001; 21: 3025-36.
9. Fei P, El-Deiry WS. P53 and radiation responses. Oncogene 2003; 22: 5774-83.
10. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985; 11: 1699-707.
11. Gewirtz DA. Commentary: a critical analysis of the mechanisms of action proposed for the anthracycline antibiotics, adriamycin and daunorubicin in the tumor cell. Biochem Pharmacol 1999; 57: 727-41.
12. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-911.
13. Guan RG, Moss SF, Arber N, Krajewski S, Reed JC, Holt PR. 30 kDa phosphorylated form of Bcl-2 protein in human colon. Oncogene 1996; 12: 2605-9.
14. Hague A, Bracey TS, Hicks DJ, Reed JC, Paraskeva C. Decreased levels of p26-Bcl-2, but not p30 phosphorylated Bcl-2, precede TGFβ1-induced apoptosis in colorectal adenoma cells. Carcinogenesis 1998; 19: 1691-5.
15. Hong JR, Wu JL. Induction of apoptotic death in cells via Bad gene expression by infectious pancreatic necrosis virus infection. Cell Death Differ 2002; 9: 113-24.
16. Liu FT, Newland AC, Jia L. Bax conformational change is a crucial step for PUMA-mediated apoptosis in human leukemia. Biochem Biophys Res Commun 2003; 310: 956-62.
17. Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005; 205: 275-92.
18. Mercatante DR, Mohler JL, Kole R. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNAsplicing and antineoplastic agents. J Biol Chem 2002; 277: 49374-82.
19. Muller WU, Bauch T, Streffer C, von Mallek D. Does radiotherapy affect the outcome of the comet assay? Br J Radiol 2002; 75: 608-4.
20. Nielsen D, Dombernowsky P, Larsen SK, Hansen OP, Skovsgaard T. Epirubicin or doxorubicin and cisplatinum as first-line therapy in advanced breast cancer. A phase III study. Cancer Chemother Pharmacol 2000; 46: 459-66.
21. Olive PL. The role of DNA single- and double-strand breaks in cell killing by ionizing radiation. Radiat Res 1998; 150: 42-51.
22. Palyvoda O, Polanska J, Wygoda A, Rzeszowska-Wolny J. DNA damage and repair in lymphocytes of normal individuals and cancer patients: studies by the comet assay and micronucleus tests. Acta Biochem Pol 2003; 50: 181-90.
23. Philchenkov AA, Stoika RS. Apoptosis and cancer. Kiev: Morion; 1999 (In Russian).
24. Sawicka M, Kalinowska M, Skierski J, Lewandowski W. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence. J Pharm Pharmacol 2004; 56: 1067-81.
25. She QB, Ma WY, Zhong S, Dong Z. Activation of JNK1, RSK2, and MSK1 is involved in serine 112 phosphorylation of Bad by ultraviolet B radiation. J Biol Chem 2002; 277: 24039-48.
26. Schmidt-Ullrich RK, Dent P, Grant S, Mikkelsen RB, Valerie K. Signal transduction and cellular radiation responses. Radiat Res 2000; 153: 245-57.
27. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res 1988; 175: 184-91.
28. Stavrovskaya AA. Cellular mechanisms of multidrug resistance of tumor cells. Biochemistry (Moscow) 2000; 65: 95-106.
29. Wells WW, Rosque PA, Xu D., Meyer EB, Charamella LJ, Dimitrov NV. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Rad Biol Med 1995; 18: 699-708.
30. Willers H, Dahm-Daphi J, Powell SN. Repair of radiation damage to DNA. British J Cancer 2004; 90: 1297-301.